Institutional Ownership
Vir Biotechnology Inc
CUSIP 92764N102COMVIRQ1 2026
Institutional Holders
243
13F filers
Shares Held
123.74M
Aggregate institutional
Institutional Value
$1.10B
Q1 2026
Net New Holders
+31
60 new · 29 closed
Institutional Ownership Trend
Aggregate 13F value by quarter
Multi-quarter trend — upgrade to see history
UpgradePosition Activity
Q1 2026
New positions60
Increased119
Decreased39
Sold out29
Institutional Holders
243 funds hold this security · Q1 2026
| # | Fund | Shares | Value | Δ Shares | Activity |
|---|---|---|---|---|---|
| 1 | Blackrock, Inc. | 18.00M | $161.27M | +1.67M | Added |
| 2 | Arch Venture Management, LLC | 12.92M | $115.73M | 0 | Held |
| 3 | Sb Investment Advisers (Uk) Ltd | 10.95M | $98.09M | −2.17M | Reduced |
| 4 | Gsk PLC | 8.55M | $76.62M | 0 | Held |
| 5 | State Street Corp | 7.14M | $63.98M | +911.5K | Added |
| 6 | Goldman Sachs Group Inc | 3.25M | $29.12M | +1.68M | Added |
| 7 | Morgan Stanley | 2.85M | $25.57M | +175.1K | Added |
| 8 | Adar1 Capital Management, LLC | 2.74M | $24.59M | +2.74M | New |
| 9 | Geode Capital Management, LLC | 2.66M | $23.82M | +329.6K | Added |
| 10 | Dimensional Fund Advisors LP | 2.58M | $23.11M | +43.4K | Added |
233 more institutional holders on Premium
See every fund holding Vir Biotechnology Inc, with full quarter-over-quarter share changes.
Unlock all holders